Loading market dashboard
Ventana Biotech, Inc.
VNTAFinancial ServicesOTCCH
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news release dated May 5, 2026, the Company has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement"). Under the Second Tranche, the Company issued 615,000 units (each, a "Unit") at a price of $1.00 per Unit, for aggregate gross proceeds of $615,000.
VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news releases dated January 29, 2026 and March 25, 2026 , the Company has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") and closed its previously announced debt settlement (the "Debt Settlement"), on the terms described herein. Private Placement The Company has closed the First Tranche of the Private Placement through the issuance of 385,000 units of the Company (each, a "Unit") at a price of $1.00 per Unit, for aggregate gross proceeds of $385,000.
Denver, Colorado--(Newsfile Corp. - March 27, 2026) - Ventana Global, Inc. (OTCID: VNTA) (the "Company") today announced the publication of
